As medical device quality assurance and regulatory affairs professionals, it can be challenging to stay on top of changes happening in our industry. Few people have the time to read lengthy articles these days and although many online newsletters exist, they are often packed with PR releases, ads or unrelated information. That is why we started this blog for QA/RA professionals in the medical device and IVD industry. The idea is to give you short updates on quality and regulatory topics that may be of interest to you.

2011年 6月 10日

Ontario Government Backs Off Requiring ESA Registration for Some Medical Device Makers

Last month, Ontario’s Ministry of Consumer Services issued a proposed amendment to the province’s product...
阅读更多
2011年 6月 13日

Draft Guidance from FDA on Regulation of Nanotechnology

Draft guidance issued June 9 th by the US Food and Drug Administration lays out possible reg
阅读更多
2011年 6月 13日

Japanese Trade Groups Urge Creation of Pan-Asian MedTech Community

The Japan Federation of Medical Device Associations (JFMDA) and the Medical Engineering Technology Industrial Strategy consortium (METIS), Japan’s two largest medical device and technology tr
阅读更多
2011年 6月 14日

FDA Proposes CDRH Restructuring, Bigger Budget to Meet MDUFA III Requirements

The US Food and Drug Administration (FDA) has floated the possibility of reorganizing the Center for Devices and Radiological Health (CDRH) and providing more resources to the branch in order to ad
阅读更多
2011年 6月 15日

New OJEC Standards, Notified Body Code of Conduct & e-Labeling

Several initiatives to improve the business and regulatory environments in the EU medical device sector...
阅读更多
2011年 6月 16日

CDRH Audit: Majority of NSE Determinations Due to Inadequate Performance Data from Sponsors

A recent audit of the Food and Drug Administration’s 510(k) program by the Center for Devices and Radiological Health (CDRH) has found that inadequate device performance data submissions from sponsors make up a substantial majority--80%--of Not Substantially Equivalent (NSE) determinations made by the agency between 2005 and 2010. The analysis covered more than 700 NSE determinations made during the course of that six-year period. NSE determinations were based either on failure to provide appropriate performance data to support substantial equivalence (SE) determinations, or to demonstrate equivalent performance compared to predicate devices.
阅读更多
2011年 6月 17日

CDRH Takes More Proactive Approach with Notice to Industry Letters

The FDA’s Center for Devices and Radiological Health (CDRH) has published a
阅读更多
2011年 6月 20日

FDA Rolls Out Global Strategy to Oversee Imports

The US Food and Drug Administration (FDA) has launched a new strategy detailed in a new report, the Pathway to Global Product Safety and Quality , to better monitor increasing numbers of imported medical devices and other regulated products hitting the US market. The report calls for a more global approach to regulation of products that fall under the FDA’s purview, recommending four initiatives to carry out the new strategy:
阅读更多
2011年 6月 23日

FDA’s Medical Device Recall Process Under Fire from GAO

A new report from the US Government Accountability Office (GAO) has found that the Food and Drug Administration (FDA) has not consistently analy
阅读更多
2011年 6月 23日

Australia, New Zealand to Establish Joint Medical Device Regulator

The governments of Australia and New Zealand are setting up a single regulatory body to oversee therapeutic goods including medical devices and pharmaceuticals across both their countries.
阅读更多

Pages